Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: The PaLiDo study, a phase II nonrandomized multicenter study.
Karina Dahl Steffensen
Research Funding - Amgen
Marianne Waldstrøm
No relevant relationships to disclose
Niels Pallisgaard
No relevant relationships to disclose
Bente Lund
No relevant relationships to disclose
Kjell Bergfeldt
No relevant relationships to disclose
Jessica Wihl
No relevant relationships to disclose
Nina Keldsen
No relevant relationships to disclose
Christian Marth
No relevant relationships to disclose
Ignace B. Vergote
No relevant relationships to disclose
Anders Kristian Moeller Jakobsen
Research Funding - Amgen